Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Alopecia areata costs individuals about 3% of their income, with women, Asians, those with lower income, and more severe symptoms spending more.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Alopecia areata treatment varies, with no optimal method established yet.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

More research is needed on alopecia areata treatments and its psychological effects.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Low vitamin D might be one of several factors involved in the hair loss condition alopecia areata.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Hair regrowth improved, but quality of life did not.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

The MPV/PC ratio can help assess disease activity in alopecia areata.

Keratin is crucial for skin barrier formation and affects mitochondrial function.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Laser-assisted drug delivery is generally safe with mostly mild side effects.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.